Novel cyclic compounds as potent phosphodiesterase 4 inhibitors

被引:25
作者
He, W [1 ]
Huang, FC [1 ]
Hanney, B [1 ]
Souness, J [1 ]
Miller, B [1 ]
Liang, GY [1 ]
Mason, J [1 ]
Djuric, S [1 ]
机构
[1] Rhone Poulenc Rorer Cent Res, Dept Med Chem, Collegeville, PA 19426 USA
关键词
D O I
10.1021/jm970575f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and biological activity of a novel series of 2,2-disubstituted indan-1,3-dione-based PDE4 inhibitors are described. This structurally unique class of PDE4 inhibitors is markedly different from the known PDE4 inhibitors such as RP 73401 (2) and CDP 840 (3). Structure-activity relationship (SAR) studies led to the identification of inhibitors with nanomolar potency and oral activity in a murine endotoxemia model for TNF-alpha inhibition. Unlike other classical PDE4 inhibitors, several analogues were found to be nonemetic in a canine emesis model at intravenous doses of up to 3 mg/kg.
引用
收藏
页码:4216 / 4223
页数:8
相关论文
共 38 条
  • [1] SELECTIVE TYPE-IV PHOSPHODIESTERASE INHIBITORS AS ANTIASTHMATIC AGENTS - THE SYNTHESES AND BIOLOGICAL-ACTIVITIES OF 3-(CYCLOPENTYLOXY)-4-METHOXYBENZAMIDES AND ANALOGS
    ASHTON, MJ
    COOK, DC
    FENTON, G
    KARLSSON, JA
    PALFREYMAN, MN
    RAEBURN, D
    RATCLIFFE, AJ
    SOUNESS, JE
    THURAIRATNAM, S
    VICKER, N
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (11) : 1696 - 1703
  • [2] Barnette MS, 1996, BIOCHEM PHARMACOL, V51, P949
  • [3] BARNETTE MS, 1995, J PHARMACOL EXP THER, V273, P1396
  • [4] CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN
    BEUTLER, B
    CERAMI, A
    [J]. NATURE, 1986, 320 (6063) : 584 - 588
  • [5] DESIGN AND SYNTHESIS OF CONFORMATIONALLY CONSTRAINED ANALOGS OF 4-(3-BUTOXY-4-METHOXYBENZYL)IMIDAZOLIDIN-2-ONE (RO-20-1724) AS POTENT INHIBITORS OF CAMP-SPECIFIC PHOSPHODIESTERASE
    BRACKEEN, MF
    COWAN, DJ
    STAFFORD, JA
    SCHOENEN, FJ
    VEAL, JM
    DOMANICO, PL
    ROSE, D
    STRICKLAND, AB
    VERGHESE, M
    FELDMAN, PL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (24) : 4848 - 4854
  • [6] SYNTHESIS AND IN-VITRO PROFILE OF A NOVEL SERIES OF CATECHOL BENZIMIDAZOLES - THE DISCOVERY OF POTENT, SELECTIVE PHOSPHODIESTERASE TYPE-IV INHIBITORS WITH GREATLY ATTENUATED AFFINITY FOR THE [H-3] ROLIPRAM BINDING-SITE
    CHENG, JB
    COOPER, K
    DUPLANTIER, AJ
    EGGLER, JF
    KRAUS, KG
    MARSHALL, SC
    MARFAT, A
    MASAMUNE, H
    SHIRLEY, JT
    TICKNER, JE
    UMLAND, JP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (17) : 1969 - 1972
  • [7] Novel heterocyclic-fused pyridazinones as potent and selective phosphodiesterase IV inhibitors
    DalPiaz, V
    Giovannoni, MP
    Castellana, C
    Palacios, JM
    Beleta, J
    Domenech, T
    Segarra, V
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (10) : 1417 - 1421
  • [8] DULPANTIER AJ, 1996, J MED CHEM, V39, P120
  • [9] DULPANTIER AJ, 1994, ANNU REP MED CHEM, V29, P73
  • [10] ESCOTT KJ, 1998, BRIT J PHARMACOL, V123, P40